News


All News

Dermatologist and Mohs surgeon Ellen Marmur, M.D., knows skin cancer. She performs about 1,000 skin cancer surgeries a year as chief of the division of dermatology and cosmetic surgery, Mount Sinai Medical Center, New York. But when a suspicious lesion showed up on her nose, she did not want to think the worst.

Dr. Cellulite prides himself on the fact that he is the only dermatologist performing mesotherapy cellulite treatments in his area. He uses a technique called "lipodissolve." He, like most healthcare practitioners doing this technique, uses a substance called deoxycholate. He advertises that this technique is both safer and more effective than liposuction.

Organized medicine, including groups representing dermatologists, has long fought for medical liability reforms that would limit jury-granted noneconomic awards for pain and suffering and include provisions to keep frivolous (but potentially costly) cases out of court. Their pitch: Effective reform would reduce medical malpractice costs, including insurance, and make it possible for many physicians who can't afford skyrocketing premiums to continue their practices.

Rosacea is a fairly common inflammatory skin condition that can prove challenging to treat. Current therapeutic strategies empirically target the signs and symptoms of the disease, because the details of its pathophysiology have not yet been completely understood.

Recent trial data show that a new lower-dose regimen of imiquimod proves effective in the treatment of actinic keratosis (AK) and allows patients to treat much larger surface areas of clinical as well as subclinical lesions. Study results were recently presented at the 68th Annual Meeting of the American Academy of Dermatology.

Although recent vitamin D research suggests that higher vitamin D levels might improve some health outcomes, these data are largely inconclusive and sometimes contradictory, dermatologists say. Moreover, they continue to recommend oral supplementation rather than intentional sun exposure for those interested in elevating their levels.

Keeping good closures from going bad requires not only thorough patient education and surgical planning by the physician, but also patient adherence to pre- and post-surgical instructions, according to an expert who spoke at the 68th annual meeting of the American Academy of Dermatology.

As an attorney and a consultant to thousands of physicians across the country, we are constantly astounded by the attitudes of physicians regarding the sale of their medical practices. Most often, we hear the complaint that doctors do not feel they can sell their practice for any significant value.

Aliso Viejo, Calif. - Valeant Pharmaceuticals, based here, will acquire Vital Science Corp., a Toronto-based manufacturer of over-the-counter dermatology products, news source Socaltech.com reports.

The Bottom Line : Derms cut back, but emphasize quality, as slow economy continues to pinch Tightening Tanning : FDA may reclassify sunbeds, set stricter limits on use by teens Special Report : Skin Cancer

Because dog-ears behave predictably, physicians can use a structured algorithm to prevent, minimize and repair them when necessary, the algorithm's developer says.

Credentialing a new doctor with third-party payers (including Medicare) is a tedious but necessary process. Even small mistakes can result in setbacks - even worse, application denials - all of which can rob dermatology practices of precious revenue, experts say.

Could e-prescribing be a boon to the operation of your practice? Or is it one more layer of bureauracy the federal government is trying to lay on physicians? On Call wondered whether dermatologists are using e-prescriptions, and if so, whether they actually like them.

Two of the most important insults the skin sustains are oxidation and glycation. Oxidative damage is the effect most familiar to the dermatologist, and it is caused by dermal protein damage from reactive oxygen species. Glycation is a second insult to the skin protein, and it is caused by the linking of sugars with dermal proteins.

Omaha, Neb. - A new treatment for actinic keratoses, known as PEP005, has completed two phase 3 trials which demonstrated that ingenol mebutate gel 0.05 percent, when used to treat actinic keratoses (AK) on the head and non-head locations, resulted in complete clearance of the lesions, when compared to vehicle.